SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-07-002661
Filing Date
2007-02-23
Accepted
2007-02-23 15:50:42
Documents
3
Period of Report
2007-02-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y30879e8vk.htm 8-K 17238
2 EX-99.1: PRESS RELEASE y30879exv99w1.htm EX-99.1 81818
3 EX-99.2: TEXTUAL REPRESENTATION OF CERTAIN PORTIONS OF THE WEBCAST CONFERENCE CA y30879exv99w2.htm EX-99.2 22533
  Complete submission text file 0000950123-07-002661.txt   123347
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 07645771
SIC: 2835 In Vitro & In Vivo Diagnostic Substances